30DEC

Libyan International Conference for Health Sciences

The First Libyan International Conference for Health Sciences (2024): Open University, Tripoli, Libya
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences
https://ppj.org.ly/article/doi/10.5281/zenodo.10607574

Mediterranean Journal of Pharmacy and Pharmaceutical Sciences

Original article

Hypotensive effect of yeast in the hypertensive rat model

Aisha M. Alfituri, Faiza A. Elhamdi, Salwa M. Alfituri, Abubaker A. Bashir, Ahmed F. Behriz, Awad G. Abdellatif

Downloads: 0
Views: 240

Abstract

Elevated arterial blood pressure is the most important public health problem in developed countries. It often leads to lethal complications if left untreated. Brewer's yeast is celebrated for its various beneficial effects, including a possible hypotensive effect. Thus, the anti-hypertensive effects of brewer’s yeast were investigated. The hypertensive model was done by a once-weekly intraperitoneal injection of dexamethasone at a dose of 25 mg/kg combined with drinking a 1.0% sodium chloride solution containing 0.2% KCl and 2.0% glucose for six weeks. The blood pressure was measured by the rat carotid artery cannulation preparation. Different doses of brewer's yeast dissolved in distilled water were injected into the internal jugular vein, with measurement of blood pressure at each time. To explore the mechanism of the hypotensive effect of yeast, the yeast cardiac effect was verified by the use of isolated perfused rabbit heart preparations using different antagonists. It was found that dexamethasone elevated systolic blood pressure to 178.3±11.6 and diastolic blood pressure to 133.3±16.6 from normal levels of 115.0±9.1 for systolic and 74.0±4.1 for diastolic. The gradual increase in intravenous yeast doses ranging from 0.05 to 0.40 effectively lowered systolic and diastolic blood pressure in rats with normal pressure, bringing them to approximately 80.0±05.6 mmHg for systolic and 40.0±3.5 mmHg for diastolic. While doses exceeding 0.04 resulted in a drop in systolic pressure to 60.0±3.9 mmHg, diastolic pressure became unrecordable. The administration of the 0.20 dose resulted in unrecordable blood pressure. In hypertensive rats, a decrease in blood pressure was observed with doses ranging from 0.60-1.0 mg, leading to a reduction to 110.0±2.8 mmHg for systolic and 52.0±9.9 mmHg for diastolic pressures. Doses exceeding 1.0 mg further lowered systolic and diastolic pressures to 20.0±3.9 mmHg. There was a mild increase in heart rate with no change in cardiac force of contraction. This effect was not mediated through beta, calcium receptors, or the histamine effect. The findings show that the yeast has a dose-dependent blood pressure-lowering effect. The mechanism of the chronotropic effect is possibly due to its direct action.

Keywords

Carotid artery cannulation, dexamethasone, hypertensive rat

References

  1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J (2016) Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 134 (6): 441-450. doi: 10.1161/CIRCULATIONAHA. 115.018912
  2. Mills KT, Stefanescu A, He J (2020) The global epidemiology of hypertension. Nat Rev Nephrology. 16 (4): 223-237. doi: 10.1038/s41581-019-0244-2
  3. Hittinger CT, Steele JL, Ryder DS (2018) Diverse yeasts for diverse fermented beverages and foods. Current Opinion in Biotechnology. 49: 199-206. doi. 10.1016/j.copbio.2017.10.004
  4. Katholi RE, Winternitz SR, Oparil SB (1983) Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in one kidney one clip gold blat hypertensive rat. Journal of Clinical Investigation. 69 (1): 55-62. doi: 10.1172/jci110441
  5. Mcleod DP, Reynolds AK (1962) Studies on some rauwolfia preparations with special reference to their effects on cardiac arrhythmias. Archives of Intern Archives Internationales de Pharmacodynamie et de Therapie. 138: 347-350. doi: Nil.                                                    
  6. Gilant AH, Aftab KM (1994) Calcium channel blocking activity of Artemisia scoparia. Phytotherapy Research. 8 (3): 145-148. doi: 10.1002/PTR.2650080309
  7. Burns JM (1952) Practical Pharmacology. Blackwell Scientific Publication, Oxford. ISBN: 1892-592717694.
  8. Friedrichs GS, Chi L, Green AL, Lucchesi BR (1994) Antifibrillatory effect of clofilium in the rabbit isolated heart. British Journal of Pharmacology. 113 (1): 209-215. doi: 10.1111/j.1476-5381.1994.tb16195.x
  9. Goodwin JE, Geller DS (2012) Glucocorticoid-induced hypertension. Pediatric Nephrology. 27 (7): 1059-1066. doi: 10.1007/s00467-011-1928-4
  10. Ong SL, Zhang Y, Whitworth JA (2009) Mechanisms of dexamethasone-induced hypertension. Current Hypertension Reviews. 5 (1): 61-74. doi: 10.2174/157340209787314315
  11. Korhonen R, Lahti A, Hämäläinen M, Kankaanranta H, Moilanen E (2002) Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Molecular Pharmacology. 62 (3): 698-704. doi: 10.1124/mol.62.3.698
  12. Hosseinzadeh P, Djazayery A, Mostafavi SA, Javanbakht MH, Derakhshanian H, Rahimiforoushani A, Djalali M (2013) Brewer’s yeast improves blood pressure in type 2 diabetes mellitus. Iranian Journal of Public Health. 42 (6): 602-209. PMID:23967428. PMCID: PMC3744257.
  13. Kanauchi O, Igarashi K, Ogata R, Mitsuyama K, Andoh A (2005) A yeast extract high in bioactive peptides has a blood-pressure lowering effect in hypertensive model. Current Medicinal Chemistry. 12 (26): 3085-3090. doi: 10.2174/092986705774933461
  14. Hosseinzadeh P, Djazayery A, Mostafavi SA, Javanbakht MH, Derakhshanian H, Rahimiforoushani A, Djalali M (2013) Brewer's yeast improves blood pressure in type 2 diabetes mellitus. Iran Journal of Public Health. 42 (6): 602-609. PMID: 23967428. PMCID: PMC3744257.
  15. Nakamura Y, Masuda O, Takano T (1996) Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Bioscience, Biotechnology and Biochemistry. 60 (3): 488-489. doi: 10.1271/bbb.60.488
  16. Amorim M, Marques C, Pereira JO, Guardão L, Martins MJ, Osório H, Moura D, Calhau C, Pinheiro H, Pintado M (2019) Antihypertensive effect of spent brewer yeast peptide. Process Biochemistry. 76: 213-218. doi: 10.1016/ j.procbio.2018.10.004
  17. Reis SA, Conceição LL, Rosa DD, Siqueira NP, Peluzio MCG (2017) Mechanisms responsible for the hypocholesterolemia effect of regular consumption of probiotics. Nutrition Research Reviews. 30 (1): 36-49. doi: 10.1017/S0954422416000226
  18. Ervin G, Erdos C, Branislav M, Marcic G (2001) Kinins receptors and inhibitors-where did they lead us. Biological Chemistry. 382: 43-47. doi: 10.1515/BC.2001.007
  19. Bartlet AL (1963) The action of histamine on the isolated heart. British Journal of Pharmacology and Chemotherapy. 21 (3): 450-451. doi: 10.1111/j.1476-5381.1963.tb02013.x
  20. Broadley KJ (1975) The role of H1-H2-receptors in the coronary vascular response to histamine of isolated perfused hearts of guinea pigs and rabbits. British Journal of Pharmacology. 54 (4): 511-524. doi: 10.1111/j.1476-5381.1975. tb07599.x
  21. Levi R, Cappurro N, Lee C (1975) Pharmacological characterization of cardiac histamine receptors: sensitivity to H1- and H2 receptor agonists and antagonist. European Journal of Pharmacogly. 30 (2): 328-335. doi: 10.1016/0014-2999(75)90117-x

Submitted date:
12/05/2023

Reviewed date:
01/25/2024

Accepted date:
01/31/2024

Publication date:
02/06/2024

65c2b7e7a9539549d5348f34 medjpps Articles
Links & Downloads

Mediterr J Pharm Pharm Sci

Share this page
Page Sections